FilingFirehose · free AI preview
Jasper Therapeutics, Inc.
JSPRW · AI-generated SEC analysis preview · refreshes when data changes
⚠️ Red flag 8-Ks: 2
Types: Delisting, Officer Departure
Jasper Therapeutics (JSPRW) filed a delisting notice on June 9, 2026, and reported an officer departure on May 21, 2026—two material governance events in the past 90 days with no detected cyber incidents. The delisting filing and leadership change warrant immediate context on timing, replacement, and underlying catalyst. The full $49 Report adds dilution risk scoring, complete 8-K narrative summaries, 12-month financing and capital structure history, and AI-flagged risk signals across executive stability and exchange compliance.
Want the full 5-section $49 Report on JSPRW?
Dilution risk score · 12 months of 8-K context · financing history · AI risk signals · bottom-line framing. Delivered in ~5 minutes.
See a real sample report →
This preview was AI-generated from FilingFirehose's SEC EDGAR ingestion pipeline.
Not investment advice. Verify all claims against original filings.